Provided by Tiger Trade Technology Pte. Ltd.

Bioxcel Therapeutics Inc.

0.7589
-0.0449-5.59%
Volume:820.42K
Turnover:649.19K
Market Cap:23.76M
PE:-0.24
High:0.8330
Open:0.8000
Low:0.7566
Close:0.8038
52wk High:5.25
52wk Low:0.7365
Shares:31.31M
Float Shares:26.89M
Volume Ratio:0.88
T/O Rate:3.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1505
EPS(LYR):-5.7255
ROE:-1766.94%
ROA:-102.43%
PB:-0.21
PE(LYR):-0.13

Loading ...

Aug 24, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 06, 2026

Major Issues Report

Form 8-K - Current report
May 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2026

Major Issues Report

Form 8-K - Current report
Apr 17, 2026

Major Issues Report

Form 8-K - Current report
Apr 01, 2026

Major Issues Report

Form 8-K - Current report
Mar 27, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2026

Major Issues Report

Form 8-K - Current report
Mar 11, 2026

Major Issues Report

Form 8-K - Current report
Feb 12, 2026

Major Issues Report

Form 8-K - Current report